In this episode, we uncover the strategic implications of Nvidia's $50 million investment in Recursion, spotlighting the convergence of AI and drug discovery. Join me for a detailed analysis of the dynamics propelling this significant financial backing.
Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: https://AIBox.ai/